Johnson & Johnson

JNJ · NYSE · USD

$256.03Change from previous close: −1.02%Absolute change: −$2.63

Close · October 2, 2026

At a glance

Revenue growth
+6.05%
2025 vs 2024
Net income growth
+90.56%
2025 vs 2024
Net margin
28.5%
2024: 15.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q2 2023
Operating cash flow8,6162,5147,3099,1693,8784,1746,9837,9935,6333,6577,8634,182
Depreciation and amortization1,9592,0042,0111,7771,9431,7721,8961,8461,7821,8151,4601,934
Capital expenditure-1,321-1,049-1,837-1,157-1,043-795-1,612-1,029-976-807-1,427-1,124
Investing cash flow-1,110-1,040-4,485-542-18,264-297-1,320-3,128-13,687-464-1,202-3,776
Financing cash flow-8,777530-1,369-8,927-5,66510,422-1,340-9,8827,544546-4,655-5,991
Dividends paid-3,227-3,131-3,131-3,132-3,129-2,989-2,984-2,985-2,985-2,869-2,865-3,092
Share repurchases-221-4,028-1,924-1,9020.0-2,127-282-539-136-1,475-216-370
Debt issued70712,4393,9131,32456517,9223,293-1,99115,3705,2651,2811,127
Debt repaid-6,455-5,225-1,808-6,467-2,941-2,871-1,758-4,440-3,827-891-2,377-8,224
Effect of exchange rates5.0-25.023.0-46.015470.0-198119-85.0-125125-97.0
Net change in cash-1,2661,9791,478-346-19,89714,3694,125-4,898-5953,6142,131-5,682
Free cash flow7,2951,4655,4728,0122,8353,3795,3716,9644,6572,8506,4363,058
Levered free cash flow6,133-1,7685,7056,3771,8102,3541,0805,4997,0542,2854,62412,411